BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2018

May 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2018-05-15

Reporting Person: Barnes Alane P (VP, General Counsel & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-15	Common Stock	M	12500	$1.42	Acquired	98268	Direct
2018-05-15	Common Stock	F	3004	$5.91	Disposed	95264	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-15	Emp. Stock Option (Right to Buy)	$1.42	M	12500	Disposed	2023-01-01	Common Stock (12500)	Direct

Footnotes

F1: Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise.